Healthcare Global Enterprises Limited (HCG) announced the outcome of its Board of Directors meeting held on February 05, 2026. The Board considered and approved the unaudited financial results for the quarter and nine months ended December 31, 2025, presenting both standalone and consolidated figures. Key decisions from the meeting include the introduction and adoption of the HCG Employee Stock Option Scheme, 2026, which is subject to shareholder and regulatory approvals. The company also approved the appointment of Dr. Naveen R. Nagar as Head - Clinical Strategy and Mr. Pankaj Gautam as Chief Information Officer, both designated as Senior Management Personnel. The financial results reveal a loss of ₹118 lakhs for the quarter ended December 31, 2025, compared to a profit of ₹1,078 lakhs in the preceding year's corresponding quarter. For the nine months ended December 31, 2025, the company reported a profit of ₹1,305 lakhs. The Board meeting commenced at 12 noon and concluded at 7:35 p.m.